The Pennant Group, Inc. (PNTG)
The Pennant Group: The Pros Of Investing Continue To Outweigh The Cons
I am maintaining my Buy rating on The Pennant Group driven by robust fundamentals and +200% stock appreciation since April 2023. PNTG delivered 36% revenue growth in 2025 and guides for 25% growth in 2026, with adjusted EPS of $1.34–$1.41 and EBITDA of $94.4–$98M. Strategic acquisitions, disciplined growth, and a culture of operational excellence underpin PNTG's expansion in home health, hospice, and senior living.
The Pennant Group (PNTG) Moves 6.3% Higher: Will This Strength Last?
The Pennant Group (PNTG) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
All You Need to Know About The Pennant Group (PNTG) Rating Upgrade to Buy
The Pennant Group (PNTG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The Pennant Group Q2 Earnings Call Highlights
The Pennant Group NASDAQ: PNTG reported second-quarter 2026 results that showed revenue and adjusted earnings growth across its home health, hospice and senior living businesses, prompting the company to raise its full-year outlook.
The Pennant Group, Inc. (PNTG) Q2 2026 Earnings Call Transcript
The Pennant Group, Inc. (PNTG) Q2 2026 Earnings Call Transcript
The Pennant Group, Inc. (PNTG) Tops Q2 Earnings and Revenue Estimates
The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.27 per share a year ago.
The Pennant Group, Inc. (PNTG) Soars to 52-Week High, Time to Cash Out?
The Pennant Group (PNTG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here is Why Growth Investors Should Buy The Pennant Group (PNTG) Now
The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.
Wall Street Analysts Believe The Pennant Group (PNTG) Could Rally 27.59%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 27.6% in The Pennant Group (PNTG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
The Pennant Group (PNTG) Upgraded to Buy: What Does It Mean for the Stock?
The Pennant Group (PNTG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
3 Reasons Why Growth Investors Shouldn't Overlook The Pennant Group (PNTG)
The Pennant Group (PNTG) possesses solid growth attributes, which could help it handily outperform the market.
The Pennant Group Q1 Earnings Call Highlights
The Pennant Group NASDAQ: PNTG reported a sharp increase in first-quarter 2026 revenue and adjusted earnings as growth in its home health and hospice business, continued senior living margin improvement and ongoing integration of newly added operations helped drive results.
